US 11559576
Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
granted A61KA61K2039/545A61K2039/572
Quick answer
US patent 11559576 (Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2039/545, A61K2039/572, A61K39/0008, A61K39/0011